CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event New debt or obligation
- 4 Open-market sale Chief Accounting Officer sold 215 shares at an average $1.25 ($268)
- 4 Open-market sale Chief Development Officer sold 435 shares at an average $1.25 ($543)
- 4 Open-market sale Chief Commercial Officer sold 469 shares at an average $1.25 ($585)
- 4 Open-market sale President & CEO sold 3,765 shares at an average $1.25 ($4,699)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 982 shares at an average $1.25 ($1,226)
Page 13 of 31 · 602 filings